Craniomandibular Osteopathy

Craniomandibular osteopathy, sometimes referred to as lion jaw or CMO, is a developmental bone disorder that affects the skull and jaw bones of growing puppies. This non-cancerous condition causes abnormal bone growth on the mandible (lower jaw), tympanic bullae (bony structures surrounding the middle ear), and occasionally other skull bones. The irregular bone proliferation creates pain, difficulty eating, and visible swelling around the jaw area. While the condition can appear alarming to pet owners, it is self-limiting in most cases, meaning the abnormal bone growth typically stops once the puppy reaches skeletal maturity around one year of age.

The underlying cause of craniomandibular osteopathy involves a disruption in normal bone remodeling during the rapid growth phase of puppyhood. In affected dogs, the balance between bone formation and bone resorption becomes dysregulated, leading to excessive bone deposition in specific areas of the skull. This abnormal bone tissue is often irregularly shaped and can interfere with normal jaw function by limiting the range of motion at the temporomandibular joint. The exact trigger for this dysregulation remains under investigation, though genetic factors play a significant role in disease development.

Craniomandibular osteopathy significantly impacts affected puppies during their growth phase. The pain associated with jaw movement can make eating and drinking difficult, potentially leading to weight loss and nutritional deficiencies if not properly managed. Puppies may show reluctance to open their mouths, drool excessively, or cry out when attempting to chew. The facial swelling that accompanies bone proliferation can also cause distress for both the puppy and the owner. Additionally, the involvement of the tympanic bullae can sometimes affect hearing or balance in severely affected individuals.

Despite its concerning presentation, craniomandibular osteopathy carries a generally favorable prognosis for most affected dogs. With appropriate supportive care focused on pain management and nutritional support, most puppies can be kept comfortable during the active phase of the disease. Once skeletal maturity is reached, the abnormal bone growth ceases, and many dogs go on to live normal, healthy lives. However, some degree of jaw dysfunction may persist in cases where extensive bone proliferation has occurred. Early veterinary intervention and consistent management are essential for ensuring the best possible outcome for affected puppies.

The primary cause of craniomandibular osteopathy is believed to be genetic in nature, with an autosomal recessive inheritance pattern identified in certain breeds. Research has demonstrated that the condition results from a mutation affecting bone metabolism during the critical growth period of puppyhood. This genetic defect disrupts the normal processes of bone formation and resorption, leading to the characteristic excessive bone deposition seen in affected animals. The hereditary nature of the disease explains why it occurs with much higher frequency in specific breeds, particularly terriers, where the genetic mutation has become established within breeding populations.

Genetic studies have made significant progress in understanding the hereditary basis of craniomandibular osteopathy. In West Highland White Terriers, Scottish Terriers, and Cairn Terriers, research has identified specific genetic markers associated with the condition. Dogs carrying two copies of the defective gene (homozygous) are most likely to develop clinical disease, while carriers with only one copy (heterozygous) may not show symptoms but can pass the mutation to their offspring. This inheritance pattern has important implications for breeding programs aimed at reducing the incidence of the disease within affected breeds.

While genetics provide the underlying susceptibility, environmental and physiological factors may influence disease expression and severity. The rapid bone growth that occurs during puppyhood appears to be a necessary condition for disease manifestation, as craniomandibular osteopathy almost exclusively affects young dogs between three and eight months of age. Nutritional factors, though not directly causative, may potentially influence the severity of bone abnormalities in genetically susceptible puppies. Some researchers have also explored whether inflammatory processes or immune system dysregulation might contribute to the excessive bone formation, though genetics remains the primary causative factor.

Risk factors for developing craniomandibular osteopathy are largely determined by breed and family history. Puppies born to parents who have produced affected offspring previously face a significantly elevated risk of developing the condition. The concentration of causative genes within certain breeding lines means that some families within affected breeds have much higher incidence rates than others. Additionally, the condition appears to affect male and female puppies with roughly equal frequency, suggesting that sex-linked factors do not play a major role in disease development.

The mechanism by which the genetic mutation leads to abnormal bone growth involves disruption of the normal bone remodeling cycle. In healthy puppies, osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells) work in coordinated fashion to shape growing bones. In craniomandibular osteopathy, this balance is disturbed, resulting in excessive osteoblast activity and inadequate bone resorption in affected areas. The skull and mandible appear particularly vulnerable to this dysregulation, possibly due to their unique developmental origins and the specific signaling pathways involved in craniofacial bone formation. The abnormal bone that forms is often poorly organized and may incorporate fibrous tissue, creating the irregular, lumpy appearance characteristic of the disease.

Early warning signs of craniomandibular osteopathy often begin subtly and may initially be mistaken for teething discomfort or minor injury. Affected puppies typically start showing symptoms between three and eight months of age, corresponding to their rapid growth phase. Pet owners may first notice that their puppy seems reluctant to play with toys, particularly those requiring vigorous chewing or tugging. There may be mild swelling along the jaw that is difficult to detect in the early stages. Some puppies develop intermittent fever that comes and goes without obvious cause. These early signs frequently go unrecognized until more dramatic symptoms develop, making awareness of the condition important for owners of high-risk breeds.

The most common symptoms of craniomandibular osteopathy involve difficulties with eating and jaw movement. Affected puppies often show marked reluctance to open their mouths fully, which can make eating kibble or harder foods challenging. Many puppies will approach their food bowl with apparent hunger but then back away after attempting to eat. Drooling frequently increases as puppies struggle to manage food in their mouths normally. Some puppies may cry out or whimper when trying to chew, indicating significant pain associated with jaw movement. Weight loss or failure to gain weight appropriately becomes a concern when eating difficulties persist over time.

Behavioral changes accompanying craniomandibular osteopathy can be significant and distressing for pet owners to witness. Puppies that were previously playful and energetic may become subdued and withdrawn due to chronic pain. There is often reluctance to be touched around the head or face, and previously friendly puppies may snap or growl when their jaw area is approached. Sleep patterns may be disrupted, with affected puppies seeming restless or unable to find comfortable resting positions. Some puppies become clingy and seek extra comfort from their owners, while others may isolate themselves. Decreased interest in normal puppy activities like playing, exploring, and socializing commonly occurs.

Physical signs of craniomandibular osteopathy become increasingly apparent as the disease progresses. Swelling along the lower jaw is often the most obvious external sign, and in severe cases, the jaw may appear noticeably thickened or misshapen. The bony prominences behind the jaw, where the mandible meets the skull, may feel enlarged and irregular when gently palpated. Facial asymmetry can develop if bone proliferation affects one side more than the other. In cases involving the tympanic bullae, swelling may be noted around the base of the ears. The jaw may feel warmer than surrounding tissues during active phases of bone proliferation due to associated inflammation.

Symptom progression in craniomandibular osteopathy typically follows a cyclical pattern, with periods of worsening alternating with periods of relative stability. During active phases, bone proliferation occurs rapidly, accompanied by increased pain, fever, and swelling. These episodes may last several days to weeks before subsiding. Between active phases, symptoms often improve, though underlying jaw dysfunction may persist. Over the course of several months, successive episodes typically result in cumulative bone changes. The severity of symptoms generally correlates with the extent of bone proliferation and the degree to which jaw movement has been compromised by abnormal bone growth.

Emergency symptoms requiring immediate veterinary attention include complete inability to open the mouth, severe dehydration due to inability to drink, extreme lethargy or collapse, and high persistent fever that does not respond to standard care. Puppies showing signs of severe pain that cannot be controlled with prescribed medications should be seen urgently. Rapid weight loss accompanied by refusal to eat any food represents a serious concern requiring intervention. Difficulty breathing or apparent respiratory distress, though uncommon, warrants emergency evaluation. Any sudden dramatic worsening of previously stable symptoms should prompt immediate veterinary consultation to rule out complications or concurrent conditions.

The initial veterinary examination for suspected craniomandibular osteopathy begins with a thorough history-taking and physical assessment. The veterinarian will ask detailed questions about when symptoms first appeared, how they have progressed, and which specific behaviors or signs the owner has observed. Particular attention is paid to the puppy's breed, age, and any family history of similar problems. Physical examination focuses on the head and neck region, with careful palpation of the mandible, skull bones, and temporomandibular joints. The veterinarian will assess the range of jaw motion, noting any pain response, crepitus, or mechanical restriction. Body temperature is recorded to check for fever, and overall body condition is evaluated to assess nutritional status.

Diagnostic imaging forms the cornerstone of craniomandibular osteopathy diagnosis, with radiographs (X-rays) serving as the primary diagnostic tool. Skull radiographs reveal the characteristic pattern of irregular bone proliferation affecting the mandible and tympanic bullae. The abnormal bone appears as areas of increased density with irregular, sometimes lumpy contours along affected structures. Multiple views are typically obtained to fully evaluate the extent of bone involvement. In some cases, sedation or anesthesia may be necessary to obtain high-quality images, as patient movement and pain can interfere with proper positioning. Advanced imaging such as computed tomography (CT) may be recommended in complex cases to provide more detailed three-dimensional assessment of bone changes.

Differential diagnosis is an important component of the diagnostic process, as several other conditions can produce similar symptoms. Osteomyelitis (bone infection) must be ruled out, particularly if there is history of trauma or dental disease. Bone tumors, though rare in young puppies, require consideration in atypical presentations. Temporomandibular joint disorders unrelated to craniomandibular osteopathy can cause jaw pain and dysfunction. Dental problems including abscesses or tooth root abnormalities may produce localized jaw swelling and eating difficulties. Masticatory muscle myositis, an inflammatory condition affecting the jaw muscles, can mimic some symptoms of craniomandibular osteopathy. The veterinarian uses the combination of signalment, clinical findings, and imaging results to distinguish between these possibilities.

Confirmation of craniomandibular osteopathy diagnosis is typically achieved through the characteristic combination of clinical presentation and radiographic findings in an appropriate patient. The classic picture involves a terrier or terrier-mix puppy between three and eight months of age with bilateral mandibular and tympanic bulla involvement visible on radiographs. In less typical presentations, additional testing may be warranted. Blood work including complete blood count and chemistry panel helps assess overall health and rule out systemic disease. Bone biopsy is rarely needed but may be considered if imaging findings are ambiguous or if other conditions cannot be confidently excluded. Once diagnosis is confirmed, the veterinarian will discuss severity grading based on the extent of bone involvement and degree of jaw function impairment, which helps guide treatment planning and prognosis.

Emergency and immediate treatment for craniomandibular osteopathy focuses on addressing acute pain and ensuring adequate nutrition and hydration. Puppies presenting during painful flare-ups require prompt pain relief to restore comfort and allow them to eat and drink. Anti-inflammatory medications, particularly non-steroidal anti-inflammatory drugs (NSAIDs) approved for use in dogs, form the foundation of immediate treatment. In severe cases where NSAIDs alone provide insufficient relief, additional pain medications may be prescribed. If the puppy is dehydrated or has lost significant weight, fluid therapy and nutritional support may be initiated. The immediate goal is to stabilize the patient and break the cycle of pain preventing adequate intake.

Medical management of craniomandibular osteopathy centers on long-term pain control and anti-inflammatory therapy throughout the active disease phase. Corticosteroids such as prednisone are frequently used for their potent anti-inflammatory effects and ability to reduce bone proliferation during active episodes. These medications are typically used cyclically, with treatment during flare-ups followed by tapering and discontinuation between episodes. NSAIDs may be used as alternatives or adjuncts to steroid therapy in some cases. Pain medications from other drug classes, including gabapentin for neuropathic pain components, may be added to the treatment regimen for puppies with inadequate response to initial therapy. Treatment protocols are individualized based on symptom severity and patient response.

Surgical intervention is rarely indicated for craniomandibular osteopathy due to the self-limiting nature of the condition. However, in severe cases where bone proliferation has caused fusion of the temporomandibular joint or significant mechanical obstruction to jaw opening, surgical options may be considered. Excision of excess bone tissue can be attempted to improve jaw mobility, though outcomes are variable and regrowth of abnormal bone may occur if surgery is performed before skeletal maturity. Surgical planning requires careful imaging evaluation and should only be undertaken by surgeons experienced with craniofacial procedures in dogs. Most veterinary specialists recommend exhausting conservative management options before pursuing surgical intervention.

Supportive care plays a crucial role in managing puppies with craniomandibular osteopathy. Dietary modification is often essential, with transition to soft foods that require minimal chewing effort. Canned food, moistened kibble, or homemade soft diets can help ensure adequate caloric intake despite jaw pain. Some puppies benefit from elevated feeding stations or hand-feeding to minimize neck and jaw movement during meals. Maintaining hydration is important, and some owners find that providing water from elevated bowls or through syringe feeding helps when drinking is difficult. Gentle physical therapy to maintain jaw mobility may be recommended, though this must be done carefully to avoid exacerbating pain.

Alternative and complementary treatment approaches may provide additional benefit for dogs with craniomandibular osteopathy. Cold therapy applied externally to swollen areas during acute flare-ups can help reduce inflammation and provide pain relief. Acupuncture has been used by some practitioners to address chronic pain associated with the condition, though controlled studies specifically for craniomandibular osteopathy are lacking. Omega-3 fatty acid supplementation may provide mild anti-inflammatory effects and support overall joint health. Physical rehabilitation focusing on maintaining jaw function and preventing muscle atrophy may be beneficial as the puppy recovers. Any complementary treatments should be discussed with the primary veterinarian to ensure compatibility with conventional therapy.

Treatment decisions are influenced by multiple factors including disease severity, patient response to initial therapy, and owner circumstances. Mild cases with minimal jaw dysfunction may require only intermittent pain management during flare-ups, while severe cases may need continuous medication throughout the active disease phase. The financial commitment for long-term management should be discussed honestly, including costs of medications, follow-up examinations, and potential complications. Owner ability to administer medications and modify feeding practices impacts treatment success. The expected duration of treatment until skeletal maturity must be communicated, along with realistic expectations about outcomes. Regular reassessment allows treatment modifications as the puppy's needs change over time.

The recovery timeline for craniomandibular osteopathy is unique compared to many other conditions because the disease is self-limiting. Active bone proliferation typically ceases when the puppy reaches skeletal maturity, generally between ten and fourteen months of age. During the months leading up to this point, owners can expect cycles of flare-ups and improvement, with gradual overall stabilization as the puppy matures. The most intense phase of the disease usually occurs between four and eight months of age, with decreasing frequency and severity of episodes as skeletal growth slows. Complete resolution of pain and inflammation typically follows within weeks to months after abnormal bone growth stops.

Post-treatment care during the active phase requires consistent attention to medication schedules, dietary modifications, and monitoring. Owners should maintain detailed records of symptom patterns, including dates of flare-ups, apparent pain levels, appetite, and weight. Follow-up veterinary appointments are typically scheduled every four to eight weeks during active disease to assess progress and adjust treatment as needed. Repeat radiographs may be performed periodically to monitor bone changes. Ensuring the puppy maintains adequate nutrition throughout this phase is critical, as growing dogs have high caloric and nutritional requirements. Compliance with prescribed medication regimens directly impacts comfort and quality of life during recovery.

Prognosis for dogs with craniomandibular osteopathy varies depending on disease severity and the extent of permanent structural changes. Dogs with mild to moderate involvement generally have excellent long-term prognosis, with complete or near-complete return to normal function after skeletal maturity. Those with severe disease involving significant temporomandibular joint compromise may retain some degree of permanent jaw dysfunction. In the worst cases, jaw fusion can occur, severely limiting mouth opening capacity and requiring lifelong dietary modifications. Factors associated with better outcomes include early diagnosis, consistent pain management, maintenance of adequate nutrition, and absence of complications such as secondary infections or severe weight loss.

Long-term outlook for most dogs that recover from craniomandibular osteopathy is positive. Once the abnormal bone growth phase ends, many dogs return to essentially normal lives without ongoing symptoms or medication requirements. Some residual facial asymmetry or jaw enlargement may persist but typically does not cause functional problems. Dogs that experienced temporomandibular joint involvement may retain mild restriction in jaw opening capacity but often adapt well. Annual veterinary examinations should include assessment of jaw function and oral health, as altered jaw mechanics may predispose some dogs to dental issues. Overall, the majority of affected dogs go on to enjoy good quality of life and normal lifespans after recovering from this challenging puppyhood condition.

Primary prevention of craniomandibular osteopathy centers on genetic management within affected breed populations. Since the condition has a clear hereditary basis, the most effective prevention strategy is avoiding breeding of affected individuals and known carriers. Dogs diagnosed with craniomandibular osteopathy should be permanently excluded from breeding programs regardless of how well they recover. Parents of affected puppies should also be removed from breeding, as they are obligate carriers of the genetic mutation. Prospective puppy buyers should inquire about family history of jaw problems in the breeding line and request health clearances from breeders.

Responsible breeding practices are essential for reducing the incidence of craniomandibular osteopathy in high-risk breeds. Breed clubs for West Highland White Terriers, Scottish Terriers, and Cairn Terriers have established health screening recommendations that include awareness of this condition. Genetic testing, where available, allows identification of carriers who can be used carefully in breeding programs with non-carrier mates to maintain genetic diversity while reducing disease incidence. Breeders committed to health improvement maintain detailed records of offspring outcomes and adjust breeding decisions based on health information. Supporting breeders who prioritize health testing helps drive improvement in breed populations over time.

While nutritional factors do not directly cause craniomandibular osteopathy, appropriate nutrition during puppyhood supports overall bone health and development. Puppies should be fed high-quality diets specifically formulated for their life stage and expected adult size. Large breed puppy formulas, designed to support controlled growth rates, may be appropriate for larger terrier breeds. Avoiding over-supplementation with calcium and other minerals is important, as excessive intake can disrupt normal bone metabolism. Maintaining healthy body condition helps ensure bones are not stressed by excess weight during the critical growth phase. Consulting with a veterinarian about appropriate feeding strategies is advisable for owners of high-risk breed puppies.

Regular veterinary care during puppyhood allows early detection if craniomandibular osteopathy begins to develop. Routine puppy wellness visits provide opportunities for veterinarians to identify emerging jaw abnormalities before they become severe. Owners of high-risk breeds should mention their dog's breed predisposition so veterinarians can include careful jaw assessment in physical examinations. Prompt attention to any signs of jaw discomfort, facial swelling, or eating difficulties enables earlier intervention if needed. Awareness of the condition among owners of predisposed breeds empowers them to recognize early symptoms and seek veterinary evaluation promptly.

Early intervention when symptoms first appear can significantly impact disease course and long-term outcomes. Beginning appropriate pain management and anti-inflammatory therapy at the first sign of flare-ups helps maintain puppy comfort and nutrition. Dietary modifications instituted early prevent weight loss and nutritional deficiencies that can complicate recovery. Close monitoring during the active disease phase allows treatment adjustments to optimize symptom control. Maintaining detailed communication with the veterinary team ensures that emerging problems are addressed quickly. While craniomandibular osteopathy cannot be cured, proactive management substantially improves quality of life during the months of active disease.

Daily management of a puppy with craniomandibular osteopathy requires adjustments to feeding routines and close attention to comfort. Meals should be offered at consistent times in a quiet, stress-free environment that encourages eating. Food consistency must be soft enough that the puppy can consume it without significant jaw effort. Many owners find success with commercial canned food, kibble soaked in warm water until very soft, or homemade diets prepared with veterinary guidance. Multiple smaller meals throughout the day may be better tolerated than two large meals. Water should be readily accessible in bowls at comfortable height, and some puppies benefit from having water added to their food to ease swallowing.

Home environment modifications help puppies with craniomandibular osteopathy remain comfortable throughout the day. Soft bedding in quiet areas provides comfortable resting spots away from household activity. Toys should be appropriate for the puppy's condition, avoiding hard chews that require vigorous jaw activity but providing mental stimulation through snuffle mats, puzzle feeders with soft treats, or gentle interactive play. The environment should be kept at comfortable temperature, as some puppies may be more sensitive to cold when experiencing inflammation. Raised food and water bowls may reduce neck strain during meals. Creating a calm, predictable routine helps reduce stress that might exacerbate symptoms.

Maintaining quality of life during active disease requires creativity and patience from owners. While affected puppies may not be able to engage in normal chewing play, they can still enjoy gentle activities, short walks appropriate to their energy level, and plenty of positive social interaction. Mental stimulation through training sessions using soft treats, nose work activities, and calm companionship helps prevent boredom. Physical contact and affection should be offered in ways the puppy finds comfortable, avoiding pressure on the jaw area. Celebrating small victories, such as good days with minimal symptoms, helps owners maintain positive perspective during challenging periods.

Ongoing monitoring throughout the disease course ensures problems are identified and addressed promptly. Owners should keep records of daily appetite, any pain behaviors observed, medication administration, and weight measured weekly. Any significant changes should be reported to the veterinary team promptly. Signs warranting immediate contact include complete refusal to eat, apparent severe pain despite medication, high fever, or any new symptoms. Regular veterinary rechecks allow objective assessment of disease progression and treatment effectiveness. Keeping a symptom diary helps veterinarians identify patterns and optimize treatment protocols. Owners should feel empowered to advocate for their puppy if current management does not seem adequate.

Caregiver support is an important but often overlooked aspect of managing craniomandibular osteopathy. Caring for a chronically ill puppy can be emotionally and financially demanding. Owners should be realistic about the time commitment involved in medication administration, modified feeding, and monitoring. Connecting with others who have experience with the condition through breed clubs or online support groups can provide valuable practical advice and emotional support. Financial planning for ongoing veterinary care and medications helps reduce stress. Taking breaks and practicing self-care allows owners to sustain the level of attention their puppy needs throughout the months of active disease. Remembering that the condition is self-limiting and that recovery is expected for most puppies provides hope during difficult periods.

West Highland White Terriers, Scottish Terriers, and Cairn Terriers are the breeds most frequently affected by craniomandibular osteopathy, with these three breeds accounting for the majority of diagnosed cases. The genetic mutation responsible for the condition appears to have originated in a common ancestor of these closely related terrier breeds and has become established within their gene pools. Within these breeds, certain lines have notably higher incidence rates due to concentration of the causative genes through breeding practices. The hereditary nature of the condition makes it particularly important for breeders of these breeds to track health outcomes and make informed breeding decisions. Owners acquiring puppies of these breeds should be educated about the condition and alert to early symptoms.

Other terrier and terrier-type breeds have also been reported to develop craniomandibular osteopathy, though less frequently than the primary three breeds. Boston Terriers, Labrador Retrievers, Great Danes, Doberman Pinschers, and various other breeds have been documented with the condition in veterinary literature. In these breeds, the condition may represent independent genetic mutations or, in some cases, might indicate terrier ancestry in the dog's background. Mixed breed dogs with terrier heritage may also be affected. The occurrence of cases across diverse breeds suggests that the underlying pathophysiology may have multiple genetic triggers. Regardless of breed, puppies showing characteristic symptoms should receive appropriate diagnostic evaluation.

Screening recommendations for breeds at risk of craniomandibular osteopathy focus on awareness and early detection rather than pre-breeding genetic testing, although genetic tests are becoming increasingly available. Breeders of high-risk breeds should maintain detailed health records on all puppies produced and share this information transparently with puppy buyers. Any puppies diagnosed with the condition should be reported to breed health registries where applicable. Puppy buyers should request documentation of health history in the breeding line. Veterinarians examining puppies of affected breeds should include careful jaw palpation and assessment of feeding comfort as part of routine wellness examinations. Breed clubs and health organizations continue to work toward improved understanding of inheritance patterns and development of broader genetic testing options to support prevention efforts.

Several conditions commonly co-occur or share features with craniomandibular osteopathy. Panosteitis, another developmental bone condition affecting young dogs, may occur in the same patient. Like craniomandibular osteopathy, panosteitis causes bone pain and is self-limiting, though it affects the long bones rather than the skull. Hypertrophic osteodystrophy (HOD) is another developmental bone disease of puppies that shares some clinical features including fever and bone pain during growth phases. These conditions represent different manifestations of bone development abnormalities and may reflect overlapping physiological disruptions during rapid growth. Dogs with one developmental bone condition may warrant monitoring for others.

Conditions producing similar symptoms that must be differentiated from craniomandibular osteopathy include masticatory muscle myositis, temporomandibular joint disorders, and bone infections. Masticatory muscle myositis causes jaw pain and swelling but affects the muscles rather than bones and can be distinguished through blood tests and imaging. Osteomyelitis of the jaw produces bone changes visible on radiographs but typically affects a single area and may be associated with dental disease or penetrating injury. Bone tumors can occur in the jaw region and must be ruled out, particularly in atypical presentations or older dogs. Accurate differentiation between these conditions is essential because treatment approaches differ significantly.

Complications that may develop in dogs with craniomandibular osteopathy include temporomandibular joint ankylosis (fusion), chronic jaw dysfunction, dental abnormalities, and secondary nutritional deficiencies. Joint ankylosis represents the most serious potential complication, occurring when abnormal bone growth bridges the joint space and restricts or eliminates jaw movement. Chronic dysfunction may persist even after disease resolution if significant structural changes have occurred. Dental crowding or malocclusion can result from altered jaw growth patterns. Nutritional deficiencies may develop if inadequate intake persists during the prolonged active disease phase. Early recognition and management of the primary condition helps minimize risk of these complications developing.